title: Echothiophate and cogeners decrease the voltage dependence of end-plate current decay in frog skeletal muscle.
abstract: The effects of three irreversible anticholinesterase agents, echothiophate (217MI), tertiary methylamine analog of 217MI (217AO) and Tetram, on end plate currents (e.p.c.s) of Rana pipiens cutaneous pectoris muscle were studied using electrophysiological techniques. All three compounds (217MI, 1-10 microM; 217AO, 1-25 microM; and Tetram, 1-50 microM) decreased the rate of e.p.c. decay (alpha) to the same extent as neostigmine (10 microM), a reversible anticholinesterase agent. Decay remained a single exponential at all membrane potentials. 217MI and its derivatives greatly reduced the normal voltage dependence of alpha represented by the slope (H = mV-1) of log alpha vs. membrane potential, in contrast to neostigmine which had no effect on H. Suppression of Ach release by the addition of 4 mM Mg++ to end-plates did not alter the reduction of H by 217AO indicating that the anticholinesterase-induced decrease in H is not simply due to an increased interaction between Ach and its receptors. Additionally, the pretreatment of end-plates with methanesulfonyl fluoride, also an irreversible cholinesterase agent, did not modify the effects of 217AO and Tetram on H. 217MI and its derivatives, at low concentrations which altered H, did not affect [3H]PCP or [125I]alpha-bungarotoxin binding to Torpedo californica Ach receptor-rich membranes. It is concluded that these agents alter H by an effect on the Ach receptor ion channel complex unrelated to either esterase inhibition or channel block.
authors: Department of Pharmacology, University of Connecticut Health Center, Farmington 06032.
authors: E G
authors: EG
authors: Henderson
authors: D J
authors: DJ
authors: Post-Munson
authors: L S
authors: LS
authors: Reynolds
authors: P M
authors: PM
authors: Epstein
mesh_terms: D000110:Acetylcholinesterase / Q000032:analysis; D000818:Animals; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D004456:Echothiophate Iodide / Q000494:pharmacology*; D066298:In Vitro Techniques; D007473:Ion Channels / Q000187:drug effects* / Q000502:physiology; D009045:Motor Endplate / Q000187:drug effects* / Q000502:physiology; D009469:Neuromuscular Junction / Q000187:drug effects*; D010622:Phencyclidine / Q000494:pharmacology; D011894:Rana pipiens; D011950:Receptors, Cholinergic / Q000187:drug effects* / Q000502:physiology; D013450:Sulfones / Q000494:pharmacology
chemical_list: D002800:Cholinesterase Inhibitors; D007473:Ion Channels; D011950:Receptors, Cholinergic; D013450:Sulfones; C005109:methanesulfonyl fluoride; D004456:Echothiophate Iodide; D000110:Acetylcholinesterase; D010622:Phencyclidine